Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
17.52
+3.49 (24.88%)
Nov 4, 2025, 11:15 AM EST - Market open
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $1.53 billion as of November 4, 2025. Its market cap has increased by 142.11% in one year.
Market Cap
1.53B
Enterprise Value
1.25B
1-Year Change
142.11%
Ranking
Category
Stock Price
$17.52
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $1.53B, an increase of 967.61%. That is a compound annual growth rate of 64.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 1.23B | 160.92% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
| Feb 5, 2021 | 143.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 807.41B |
| Johnson & Johnson | 451.02B |
| AbbVie | 382.87B |
| UnitedHealth Group | 302.39B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Abbott Laboratories | 217.76B |
| Novo Nordisk | 216.34B |